Enzymes Market to Reach USD 10.59 Billion with 5.7% CAGR: AMR
January 15, 2021 09:30 ET
|
Allied Market Research
Portland, OR, Jan. 15, 2021 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Enzymes Market by Type (Protease, Carbohydrase, Lipase, Polymerase and Nuclease, and Other Types),...
Global Enzymes Market to Surpass USD 17,875.7 Million and Rise at a CAGR of 9.4% Owing to COVID-19 Chaos by 2026 – Exclusive Report [150 Pages] by Research Dive
December 15, 2020 09:05 ET
|
Research Dive
New York, USA, Dec. 15, 2020 (GLOBE NEWSWIRE) -- As per a Research Dive published report, the global enzymes market valued for $8,900.0 million in 2018 and is estimated to surpass $17,875.7 million...
Antiseptics and Disinfectants Market to Reach USD 30.17 Billion By 2027 | CAGR of 6.6%: Reports and Data
December 11, 2020 11:09 ET
|
Reports and Data
New York, Dec. 11, 2020 (GLOBE NEWSWIRE) -- The rising occurrences of infectious diseases and growing awareness of sanitation among consumers is boosting the demand of the market. The Global...
Codexis and Molecular Assemblies Partner to Transform the Field of DNA Synthesis
June 23, 2020 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif. and SAN DIEGO, June 23, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, and Molecular...
Codexis Announces the Election of New Directors at its Annual Meeting of Stockholders
June 16, 2020 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, announces the election of new...
Codexis and Alphazyme Partner to Offer Novel Enzymes to Life Science and Diagnostic Markets
June 01, 2020 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif. and JUPITER, Fla., June 01, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, and Alphazyme...
Codexis to Participate in Two Virtual Investment Conferences
May 27, 2020 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., May 27, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will participate in two virtual investment...
Codexis to Present at the UBS Virtual Healthcare Conference
May 11, 2020 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., May 11, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will present at the UBS Virtual Healthcare...
Codexis Reports First Quarter 2020 Financial Results
May 07, 2020 16:05 ET
|
Codexis, Inc.
R&D revenue increased 26% to $9.6 million fueled by the Novartis and Takeda strategic collaborations Withdraws 2020 financial guidance due to uncertainty of COVID-19 potential impact Conference...
Codexis Achieves Technology Transfer Milestone with Global Pharmaceutical Leader
May 06, 2020 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc., a leading protein engineering company and developer of novel biotherapeutics, announces achievement of the Wave 2 milestone...